Sources | Names Used |
---|---|
CTRPv2 | BRD-K42260513 |
PharmacoGx | BRD-K42260513 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AL591806.1 | CTRPv2 | pan-cancer | AAC | 0.45 | 7e-17 |
mRNA | CD3D | CTRPv2 | pan-cancer | AAC | 0.43 | 1e-16 |
mRNA | CD1A | CTRPv2 | pan-cancer | AAC | 0.43 | 2e-16 |
mRNA | CD1B | CTRPv2 | pan-cancer | AAC | 0.42 | 2e-16 |
mRNA | OSM | CTRPv2 | pan-cancer | AAC | 0.44 | 2e-16 |
mRNA | ATP6AP1L | CTRPv2 | pan-cancer | AAC | 0.43 | 4e-16 |
mRNA | RGPD4 | CTRPv2 | pan-cancer | AAC | 0.43 | 5e-16 |
mRNA | LTB | CTRPv2 | pan-cancer | AAC | 0.44 | 5e-16 |
mRNA | SMPD3 | CTRPv2 | pan-cancer | AAC | 0.43 | 1e-15 |
mRNA | TASP1 | CTRPv2 | pan-cancer | AAC | 0.43 | 1e-15 |